University funding for the ORU reverts to the VCR to fund needs and opportunities for other ORUs, including new ORU proposals. Space assigned to the ORU reverts to the to the unit that provided it, unless other arrangements have been made. The ORU Director, in consultation with the VCR and the management of the recipient unit, must develop a plan for the return of space during the phase-out period.
GMRA VERIFY DATA extended action This protocol will be activated whenever a reaction is Verified. Listed below are the variables that will be defined for that reaction. Variables: GMRAPA = The Internal Entry Number of the reaction in File 120.8 (PATIENT ALLERGIES) GMRAPA(0) = The zero node of the entry in file 120.8. Below is a description of the data for that node. $P Field name Field type --------------------------------------------------------------- 1 PATIENT Pointer to File 2 (PATIENT) 2 REACTANT Free Text of Reaction 3 GMR ALLERGY Variable Pointer * 4 ORIGINATION DATE/TIME Date/Time (FileMan format) 5 ORIGINATOR Pointer to File 200 (NEW PERSON) 6 OBSERVED/HISTORICAL Set of Codes (o=Observed,h=Historical) 12 ORIGINATOR SIGN OFF Set of Codes (1=Signed,(Zero or Null)=Unsigned) 14 MECHANISM Set of Codes (U=Unknown,P=Pharmacologic,A=Allergy) 16 VERIFIED Set of Codes (1=Verified,(0 or Null)=Not Verified) 17 VERIFICATION DATE/TIME Date/Time (FileMan format) 18 VERIFIER Pointer to File 200 20 ALLERGY TYPE Free Text/Set of Codes 1 to 3 characters long (Where "D" = Drug, "F" = Food, "O" = Other) *The GMR ALLERGY field is a variable pointer which points to one of five possible files. They are: File Name File Reference --------- -------------- GMR ALLERGIES GMR(120.8, (e.g., 212;GMR(120.8,) NATIONAL DRUG PSNDF( DRUG PSDRUG( DRUG INGREDIENTS PS(50.416, VA DRUG CLASS PS(50.605,
GMRA MEDWATCH DATA COMPLETE extended action This protocol will be activated whenever a reaction has a MEDWatch form entered. Listed below are the variables that will be defined for that reaction. Variables: GMRAPA = The Internal Entry Number of the reaction in File 120.8 (PATIENT ALLERGIES) GMRAPA(0) = The zero node of the entry in File 120.8. Below is a description of the data for that node. $P Field name Field type --------------------------------------------------------------- 1 PATIENT Pointer to File 2 (PATIENT) 2 REACTANT Free Text of Reaction 3 GMR ALLERGY Variable Pointer * 4 ORIGINATION DATE/TIME Date/Time (FileMan format) 5 ORIGINATOR Pointer to File 200 (NEW PERSON) 6 OBSERVED/HISTORICAL Set of Codes (o=Observed,h=Historical) 12 ORIGINATOR SIGN OFF Set of Codes (1=Signed,(Zero or Null)=Unsigned) 14 MECHANISM Set of Codes (U=Unknown,P=Pharmacologic,A=Allergy) 16 VERIFIED Set of Codes (1=Verified,(0 or Null)=Not Verified) 17 VERIFICATION DATE/TIME Date/Time (FileMan format) 18 VERIFIER Pointer to File 200 20 ALLERGY TYPE Free Text/Set of Codes 1 to 3 characters long (Where "D" = Drug, "F" = Food, "O" = Other) GMRAPA1 = The Internal Entry Number of the reaction in File 120.85 (ADVERSE REACTION REPORTING) GMRAPA1(0) = The zero node of the entry in File 120.85. Below is a description of the data for that node. $P Field name Field type --------------------------------------------------------------- 1 DATE/TIME OF EVENT Date/Time (FileMan format) 2 PATIENT Pointer to File 2 (PATIENT) 3 QUESTION #1 Set of Codes (y=YES,n=NO) 4 QUESTION #2 Set of Codes (y=YES,n=NO) 5 QUESTION #3 Set of Codes (y=YES,n=NO) 6 QUESTION #4 Set of Codes (y=YES,n=NO) 7 QUESTION #5 Set of Codes (y=YES,n=NO) 8 NO. DAY HOSPITALIZED Numeric 9 QUESTION #6 Set of Codes (y=YES,n=NO) 10 QUESTION #7 Set of Codes (y=YES,n=NO) 11 QUESTION #8 Set of Codes (y=YES,n=NO) 12 DATE MD NOTIFIED Date/Time (FileMan format) 13 OBSERVER Pointer to File 200 (NEW PERSON) 14 SEVERITY Set of Codes (1=Mild, 2=Moderate, 3=Severe) 15 RELATED REACTION Pointer to File 120.8 (PATIENT ALLERGIES) 16 QUESTION #9 Set of Codes (y=YES,n=NO) 17 QUESTION #10 Set of Codes (y=YES,n=NO) *The GMR ALLERGY field is a variable pointer which points to one of five possible files. They are: File Name File Reference --------- -------------- GMR ALLERGIES GMR(120.8, (e.g., 212;GMR(120.8,) NATIONAL DRUG PSNDF( DRUG PSDRUG( DRUG INGREDIENTS PS(50.416, VA DRUG CLASS PS(50.605,
Watch the press talk about cryptocurrencies and you might believe that there was only one digital coin and only one way to invest. In fact, the technology that underpins bitcoin was always meant to be open source. The blockchain concept has now been replicated and is being used to power hundreds of different altcoins that can all be bought and sold on digital exchanges.

Now imagine that instead of you being just one person, we could make you into millions of people. And we would tell the millions of you to go and find the way out of the maze.  Each one of you would go in a different direction at the same time at incredible speed.  Certainly one of you would find the exit to the maze in a matter of milliseconds.  That is quantum computing.
Bankrate.com is an independent, advertising-supported publisher and comparison service. Bankrate is compensated in exchange for featured placement of sponsored products and services, or your clicking on links posted on this website. This compensation may impact how, where and in what order products appear. Bankrate.com does not include all companies or all available products.
For more than 50 years, Moore’s Law has reigned supreme. The observation that the number of transistors on a computer chip doubles roughly every two years has set the pace for our modern digital revolution—making smartphones, personal computers and current supercomputers possible. But Moore’s Law is slowing. And even if it wasn’t, some of the big problems that scientists need to tackle might be beyond the reach of conventional computers.
The IOTA/Tangle network supports transactions between devices by simply verifying each new transaction against two previous transactions at random on the network, meaning it is an instant, less centralised and more scalable system than blockchain and it doesn’t rely on miners. Each new active device cleverly contributes to the overall processing power of the Tangle chain.
Qualifications of the Director. At the least, an ORU director must be a tenured member of the academic senate serving at 100% effort. The director should be a leader in his/her field, as evidenced by publications, research grants, appointment to review panels, etc. Directors should also have evidence of administrative capabilities suitable for overseeing a multi-investigator and multi-disciplinary unit.

It is very common to have multiple messages put into a single file without utilizing HL7 batch protocol (i.e. without batch headers and trailers) or instead utilizing some other custom format. Working with non-HL7 formatted batch files requires some specialized processing to read and parse the messages, and may present some additional interfacing challenges.
The Director of an ORU, who must be a tenured faculty member, is appointed by the Vice Chancellor for Research. Directors are generally appointed for a five-year term with the possibility of reappointment, and report to the Vice Chancellor for Research. Appointment or reappointment of the Director is part of the ORU establishment or renewal process. The appointment of a new Director at a time when the ORU is not under review requires that the Office of Research solicit nominations from the ORU membership.

GMPL EDIT NOTES action This action will allow editing of comments that have previously been appended to a problem entry. Notes will be displayed for editing only if the current user is the author of the note; accessing this action through the Manager's Menu will set a flag allowing all notes for the current problem to be displayed and edited. D NTES^GMPLEDT4 D CK^GMPLEDT3


The ad-free site is primarily focused on artists and creative people. It also promises not to sell user information to third-parties or enforce a real-name policy. Ello claims it is about “audacity, beauty, simplicity and transparency”. The best way of describing Ello would as a combination of Pinterest, Tumblr and Deviant Art. It’s much like an alternative social networking version of LindedIn, but for visual artists.
PSJ LM PADE ACTIVITY action This displays all Pharamcy Automated Dispensing Equipment (PADE) activity for the current patient. The display includes the Date and Time the activity occured, the type of activity, the drug item, the quantity, and the PADE cabinet/dispensing device. This hidden action is available in Inpatient Order Entry. D PADECK^PSJPADPT
Some of the earliest criticisms of the Word of Faith movement came from ORU faculty members including Professor Charles Farah and one of his students, Daniel Ray McConnell. McConnell submitted a PhD thesis to the university detailing his assertion that the teachings of the movement are heretical. This was later published as A Different Gospel in 1988.[80]
Facebook has also been caught selling our data to every corporation and organization that comes a-knocking – even really nefarious ones like the CIA and Cambridge Analytica. And let’s not forget that Facebook also owns two of the other most popular social media sites in the world: Whatsapp and Instagram. Do you really feel comfortable using those now?

GMTS TR action This component contains information extracted from the MAS package. Time and occurrence limits apply to this component. Data presented include: transfer date, type, destination, and provider (when available). Note: The occurrence limits are determined by the occurrence of admissions. S:'$D(DFN)&$D(ORVP) DFN=+ORVP S GMTSPRM="TR",GMTSTITL="TRANSFERS" D ENCWA^GMTS


Term of Service: Directors are at will appointees normally appointed to five year terms.  After the effectiveness of each Director has been reviewed near the end of his/her initial five year term, renewal for a second five year term may, and often does, occur.  In compliance with UCOP policy governing the administration of ORUs, Directorships of ORUs are limited to ten years of continuous tenure in all but extraordinary circumstances.

Dash had a similarly positive 2017 to the rest of the major altcoins out there, rising from $10 per token to a peak of more than $1,200 towards the end of the year. It’s settled down to around $800 since then, but that still represents a huge rise over the past 12 months and brings it squarely into the top 20 cryptocurrencies in terms of market-cap.


LA7 LAB RESULTS ACTION action Action protocol to setup sending lab results to HL7 message subscribers via protocol LA7 LAB RESULTS AVAILABLE (EVN) - Lab Results Available Event. This protocol should be attached to protocol LAB RESULTS => EXTERNAL PACKAGE [LR7O ALL EVSEND RESULTS] which is an extended action protocol triggered by the lab result verification process. D QUEUE^LA7HDR
PSJU OR VBW action This allows the user to verify (or take other actions) on non-verified Unit Dose orders for patients. If the user is a pharmacist, this protocol will show all orders not verified by a pharmacist for a ward group, ward, or single patient, as the user chooses. If the user is a nurse, this protocol will show all orders not verified by a nurse. If the user is ward staff, this protocol will show patients with orders not verified by a nurse, but not allow any action to be taken. D ^PSGVBW
PSJU OR PAT DS action This gives the physician and/or Outpatient Pharmacy a report of the active Unit Dose medications for a patient about to be discharged or transferred to Authorized Absence, and allows the physician to mark the appropriate action deemed necessary for each medication. This protocol assumes that a patient has already been selected. D ENOR^PSGDS
IBCEM CSA MULTI SELECT REVIEW action This option allows the selection of more than 1 status message and allows the user to either automatically mark the messages as reviewed or allows the user to ask to see each message to determine whether or not it can be marked as reviewed. In either case, the result is that the message is marked as review completed, the review action is changed to FILED - NO ACTION and a review comment is entered noting the auto-review action and who the user was who performed it. D MSTAT^IBCEU0 <<
×